MEDICLIN Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was EUR 355.35 million compared to EUR 323.12 million a year ago. Revenue was EUR 361.13 million compared to EUR 329.35 million a year ago. Net income was EUR 2.3 million compared to net loss of EUR 15.59 million a year ago. Basic earnings per share from continuing operations was EUR 0.05 compared to basic loss per share from continuing operations of EUR 0.33 a year ago. Diluted earnings per share from continuing operations was EUR 0.05 compared to diluted loss per share from continuing operations of EUR 0.33 a year ago.